Chainlink price in focus after Moody's multichain ratings pilot
Ethena USDe price holds as lending oversight shifts
Ethereum price holds near USD 2,057 as ETF outflows and upgrade risks weigh
Bitcoin-Cash price in focus as quantum-signature review nears deadline
Mercedes-Benz Expands Electric VLE Lineup as Analysts Question the Cash Behind the Green Pledge
Deutz Orders Outpace Revenue by Threefold as Analysts Split on Fair Value
NEAR Protocol price weighs governance-approved issuance cut
XRP price falls 5.12 percent as ETF outflows test support
KWS posts good start to fiscal year 2026 / 2027 and confirms forecasts
BioVersys and partners to present AlpE data at The Union World Conference on Lung Health
E.ON reaffirms 2026 guidance and continues to invest in Europe’s energy infrastructure
Zehnder Group consolidates its heat exchanger production in Europe at its site in Reinsdorf (DE)
XPeng's European Ambitions Meet a Harder Yardstick: October's Delivery Surge
Infineon's €20 Billion Growth Plan Hinges on Customer Commitments and a Free Cash Flow Test
Deutsche Telekom Draws Fresh Buy Calls After ECB Nod and AI Buildout, Even as Payout Falls Short
BioNTech Pays $205 Million for a Regulatory Shortcut as Its Rebound Faces an Internal Test
Munich Re's Buyback and Raised Guidance Meet a Wall of Analyst Caution
Palantir's Insurance Rollout Meets a Contract-Slowdown Test
Deutsche Bank Draws Two Kinds of Conviction: Amundi's Capital and Goldman's Target
BMW's 2026 Guidance Nears Break-Even as Supply Snags Hit Three Plants and S&P Trims Credit Rating
Novo Nordisk Opens Oral Wegovy in Mexico as Buyback and Raised Guidance Round Out the Story
State Street Takes 4% Stake in T1 Energy as G2_Austin Buildout Faces Its First Real Test
Deutsche Bank Reaffirms Renk as Buy With €73 Target After Nine-Month Beat
Energy Fuels: A Paper Loss, a Completed Acquisition, and a Processing Run That Has to Happen
SAP Fixes Four Top-Severity Holes as JPMorgan Turns Bullish and AstraZeneca Signs On
Aurora Cannabis Shareholders Weigh Two Takeover Paths as Curaleaf Clears Regulatory Hurdles
Bechtle's Swiss Services Push Meets a Harder Profit Test